|
Volumn 39, Issue 9, 2002, Pages 826-829
|
Rationalization of an antiepileptic drug formulation
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BARBITOIN;
DILANTIN P;
EPILEPTIN;
EPSOLIN;
FENTOIN ER;
GAROIN;
MEPHENYTOIN;
P BARB;
PHENOBARBITAL;
PHENOBARBITAL PLUS PHENYTOIN;
PHENYTAL 30;
PHENYTAL 50;
PHENYTOIN;
PNA;
UNCLASSIFIED DRUG;
ANTICONVULSANT THERAPY;
ATHETOSIS;
CASE REPORT;
CLINICAL FEATURE;
DIAGNOSTIC ERROR;
DISEASE COURSE;
DOSE CALCULATION;
DOSE RESPONSE;
DRUG BIOAVAILABILITY;
DRUG BLOOD LEVEL;
DRUG CAPSULE;
DRUG FORMULATION;
DRUG INTOXICATION;
DRUG MARKETING;
DRUG OVERDOSE;
DYSTONIA;
FEVER;
FOLLOW UP;
HUMAN;
LOADING TEST;
MALE;
MUSCLE HYPERTONIA;
NEUROLOGIC DISEASE;
PRESCHOOL CHILD;
PRESCRIPTION;
SEIZURE;
SHORT SURVEY;
SKULL FRACTURE;
SUSPENSION;
TABLET;
TREATMENT OUTCOME;
ANTICONVULSANTS;
CHEMISTRY, PHARMACEUTICAL;
CHILD, PRESCHOOL;
HUMANS;
MALE;
MEDICATION ERRORS;
PHENYTOIN;
THERAPEUTIC EQUIVALENCY;
|
EID: 0036732604
PISSN: 00196061
EISSN: None
Source Type: Journal
DOI: None Document Type: Short Survey |
Times cited : (3)
|
References (13)
|